Ian W. Malone

N-able Technologies, Inc. provides information technology services for managed service providers. It provides network monitoring and remote systems management software. The company was founded in 2000 and is headquartered in Ottawa, Canada.

Seprotech Systems, Inc. provides engineered water and wastewater treatment solutions to the municipal/land development, resource sector and military market place, including Reverse Osmosis water purification systems, ROTORDISK biological sewage treatment package plants and CrystalBlue membrane-based water recycling systems. The company was founded on September 6, 1985 and is headquartered in Ottawa, Canada.

SillaJen Biotherapeutics, Inc. develops and commercializes cancer therapeutics. It focuses on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for solid tumors. It is focused on two main programs, lead product candidate, which is in mid-stage clinical development for the treatment of advanced primary liver cancer and colorectal cancer and JX-929 which is under investigation for a variety of other solid tumors. The company was founded by John C. Bell and David H. Kirn in 2006 and is headquartered in San Francisco, CA.

PharmaGap, Inc. engages in developing novel peptide therapeutics for the treatment of cancer. The company was founded by Robert Letellier, Jenny Phipps and Michel Phipps on October 6, 1999 and is headquartered in Ottawa, Canada.

World Heart Corp. develops artificial heart and related technologies. The company was founded on April 1, 1996 and is headquartered in Salt Lake City, UT.

Millenium Biologix Corp. is focused on the development and commercialization of next generation, skeletal tissue regeneration products and implantable medical devices, initially targeted for orthopedic uses. These products, used alone or in combination configurations, promote the repair and natural healing of human bone and other skeletal tissues such as cartilage. Millenium's strength in developing leading treatments for regenerative medicine is based on its successful integration of three core competencies in advanced biomaterials, biologics and engineering. Its core business activities are focused on tissue engineering products, and on orthobiologicals. It was founded on April 1, 1998 and is headquartered in Kingston, ON.